US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist
  • 1.380
  • +0.010+0.73%
Close Dec 20 16:00 ET
  • 1.380
  • 0.0000.00%
Post 20:01 ET
189.87MMarket Cap-3.94P/E (TTM)

Compass Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Compass Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q2850.000K / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q2850.000K / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Compass Therapeutics Earnings Reports

  • Compass Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 01:23

  • Compass Therapeutics | 8-K: Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update

    Nov 12 22:30

  • Compass Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 20:05

  • Compass Therapeutics | 8-K: Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update

    Aug 12 20:05

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data